Delivery Order SPE2DB22D1017-SPE2DB25FG5BB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,249.48 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pen (0.5ml), a diabetes medication. The contract, awarded on August 26, 2025, with an ultimate completion date of August 27, 2025, was competitively awarded with no set-aside designation and employs firm fixed-price pricing. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,176.72 for Mounjaro 10 mg/0.5 ml pen (0.5ml) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed price, non-set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction for this diabetes medication under a larger contract vehicle. This award is a child delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,897.78 to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pens (a diabetes medication) on September 3, 2025, with a completion date of September 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a relatively small transaction within...
- The Defense Logistics Agency awarded a $5,843.98 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens (0.5 mL quantity). This firm fixed price delivery order, with an ultimate completion date of August 21, 2025, represents a pediatric/adult diabetes medication procurement supporting military healthcare operations. The contract utilizes no set-aside designation and was competitively awarded through open procurement, with performance...
- The Defense Logistics Agency awarded a delivery order valued at $1,632.54 to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 ml pen (0.5 ml), a diabetes medication. This firm fixed-price contract, awarded on October 31, 2025, is scheduled for completion by November 3, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order was not subject to a set-aside designation and was competitively awarded through open competition....
- The Defense Logistics Agency awarded a delivery order valued at $1,607.06 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pen (0.5 mL), a diabetes medication. This competitively awarded, firm fixed price contract was executed on July 24, 2025, with an ultimate completion date of July 25, 2025. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,632.54 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen (0.5ml), a diabetes medication. This firm fixed price, competitively awarded delivery order was executed on August 6, 2025, with an ultimate completion date of August 7, 2025. The contract performs at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award derives from AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a delivery order valued at $2,809.48 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. The award was made on November 20, 2025, with an ultimate completion date of November 21, 2025, under firm fixed price terms with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,107.36 firm fixed price delivery order on November 6, 2025, for Mounjaro 7.5 mg/0.5 ml pen (0.5ml), a diabetes medication, with completion targeted for November 7, 2025. This non-set-aside award represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The product will be delivered to Conshohocken, Pennsylvania, the vendor's corporate headquarters location. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,539.11 to AmerisourceBergen Drug Corp for Mounjaro 2.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. The award was issued on November 13, 2025, with an ultimate completion date of November 14, 2025, and represents a firm fixed price contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG5BBDelivery Order
The Defense Logistics Agency awarded a $1,769.95 firm fixed price delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen (0.5 ml), a diabetes medication, on June 16, 2025. The award was completed through a non-set-aside competitive procurement and is scheduled for delivery by June 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs, particularly supporting military and veteran healthcare systems. This delivery order represents a child contract issued under AmerisourceBergen Drug Corp's larger indefinite delivery contract vehicle. This delivery order falls under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. The DLA Troop Support Medical utilizes this flexible contract structure to source specialty medications, brand-name and generic drugs, and related medical commodities for customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 6/16/25 |